The Lighthouse Clinical Study is currently enrolling children and adults with Lennox-Gastaut Syndrome (LGS) to evaluate a new potential treatment. The goal of this study is to learn whether an investigational medication called clemizole can help reduce the number of seizures when added to a person’s current antiseizure medications.
If someone you care about continues to experience frequent seizures despite being on medication, this clinical trial might be an option worth exploring.
Study Sites in the United States:
- Kissimmee, Florida
- Raleigh, North Carolina
Additional Information:
Visit the Lighthouse Clinical Study Website
View the Lighthouse Clinical Study Poster
View the Lighthouse Clinical Study Brochure
The information here is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. The content provided is for informational purposes only. LGS Foundation is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health-related diagnosis or treatment options.
Updated 04/16/25 KK